G6PD deficiency: Its role in the high prevalence of hypertension and diabetes mellitus

Ethnicity and Disease

Volumn 11, Issue 4, 2001, Pages 749-754

  Gaskin, Robert St C ^a   Estwick, David ^a   Peddi, Rajeshwar ^a  

^a Geriatric Hospital   (Barbados)

Author keywords

Blacks; Diabetes Mellitus; G6PD Deficiency; Hypertension; Nitric Oxide; Oxidative Stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BIOSYNTHESIS; BLOOD; COMORBIDITY; DIABETES MELLITUS; ENZYMOLOGY; ERYTHROCYTE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; REVIEW;

BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS; ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN; HYPERGLYCEMIA; HYPERTENSION; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE;

EID: 0035465325     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ramachandran A, Snehalatha C, Latna E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia. 1997; 40:232-237.
2. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension and cardiovascular disease: which role for oxidative stress? Metabolism. 1995; 44:363-368.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1998;37:1595-1607.
4. Ono Y, Aoki S, Ohriski Y, Yasuda T, Kawano K, Tsuday Y. Increased serum levels of advanced glycation end products in NIDDM with diabetic complications. Diabetes Care. 1998;21:1027.
5. Koltai MZ, Hadhazy P, Posa I, et al. Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res. 1997;34:157-163.
6. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. Cardiovasc Pharmacol. 1998; 32(suppl 3):S54-S61.
7. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet. 1997;350(suppl 1):S9-S13.
8. Pieper GM, Langenstroer P, Sieneich W. Diabetic induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res. 1997;34: 145-156.
9. Panza JA, Quyyumi MD, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
10. Browne E. The inheritance of an intrinsic abnormality of the red blood cell predisposing to drug induced hemolytic anemia. Johns Hopkins Med J. 1957;101:115-118.
11. Szeinberg A. Investigation of genetic polymorphic traits in Jews: a contribution to the study of population genetics. Isr J Med Sci. 1973;9:1171-1178.
12. Siniscalco M, Bernini L, Latte B, Motulsky AG. Favism and thalassemia in Sardinia and their relation to malaria. Nature. 1985;313:793-795.
13. Gepli AP. Glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia: a survey. Blood. 1965: 25:486-493.
14. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized Black male patients. N Engl J Med. 1979;300: 1001-1005.
15. Zuo I, Chen E, Du CS, Chang CN, Chiu DTY. Genetic study of Chinese G6PD variants by direct PCR sequencing [abstract]. Blood. 1990;76(suppl 51A).
16. Vives-Corrons JL, Kuhl W, Pujades MA, Beutler E. Molecular genetics of G6PD Mediterranean variant and description of a new G6PD mutant, G6PD Andalus13611A. Am J Hum Genet. 1990;47: 575-579.
17. Beutler E, Kuhl W. The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am J Hum Genet. 1990;47:1008-1012.
18. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 1991;324:169-174.
19. Vane JR, Anggard K, Bottling R. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27.
20. Rees DD, Palmer RMJ, Moncada S. The role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
21. Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chin DT. Impaired production of nitric oxide, superoxide and hydrogen peroxide in glucose 6-phosphate dehydrogenase deficient granulocytes. FEBS. 1998;436:411-414.
22. Brownlee M. Glycation and diabetic complications. Diabetes. 1994;43:8336-8341.
23. Porte D, Khan S. Hyperproinsulinemia and amyloid in NIDDM. Clues to the etiology of islet cell dysfunction? Diabetes. 1989;28:1333-1338.
24. Jenkins DJA, Wolever TMS, Thorne MJ, et al. The relationship between glycemic response, digestibility and factors influencing the dietary habits of diabetics. Am J Clin Nutr. 1984;40:1175-1191.
25. Porta M. The effects of high glucose on endothelial cell function. In: Rifkin H, Colwell JA, Taylor SL, eds. Diabetes. Amsterdam, Netherlands: Elsevier Science Publishers; 1991:683-688.
26. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 1997;96: 25-28.
27. Stehouwer CDA, Lambert J, Donker AJM, van Hinsbergh VWM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res. 1997;34:55-68.
28. Bowen JE, Murray RE. Genetic Variation and Disorders in People of African Origin. Baltimore, Md: Johns Hopkins University Press; 1990.
29. Cardillo C, Kilcoyne CM, Cannon RO III, Panza JA. Racial differences in nitric oxide vasodilation response to mental stress in the forearm circulation. Hypertension. 1998;31(6):1235-1239.
30. O'Dea K. Westernization and non-insulin dependent diabetes in Australian Aborigines. Ethn Dis. 1991:2:171-187.
31. Gaskin R. Diet, diabetes, hypertension and Blacks. Ethn Dis. 1999;9:272-277.
32. Teuscher T, Baillod P, Rosman JB, Teuscher A. Absence of diabetes mellitus in a rural West African population with a high carbohydrate/cassava diet. Lancet. 1987;1:765-768.